MedCap AB (publ)
STO:MCAP

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
STO:MCAP
Watchlist
Price: 543 SEK -4.57%
Market Cap: 8B SEK
Have any thoughts about
MedCap AB (publ)?
Write Note

MedCap AB (publ)
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MedCap AB (publ)
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
MedCap AB (publ)
STO:MCAP
Net Income (Common)
kr227.9m
CAGR 3-Years
44%
CAGR 5-Years
48%
CAGR 10-Years
32%
AddLife AB
STO:ALIF B
Net Income (Common)
kr190m
CAGR 3-Years
-28%
CAGR 5-Years
8%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Net Income (Common)
-kr2B
CAGR 3-Years
-245%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Net Income (Common)
kr257m
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
17%
G
Genovis AB
STO:GENO
Net Income (Common)
kr17.3m
CAGR 3-Years
14%
CAGR 5-Years
30%
CAGR 10-Years
N/A
M
Magle Chemoswed Holding AB
STO:MAGLE
Net Income (Common)
kr12.2m
CAGR 3-Years
89%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

MedCap AB (publ)
Glance View

Market Cap
8B SEK
Industry
Life Sciences Tools & Services

MedCap AB is an investment company engaged in biotechnology and medical technology capital investments. The company is headquartered in Solna, Stockholm. The company went IPO on 2006-07-04. The firm reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.

MCAP Intrinsic Value
430.11 SEK
Overvaluation 21%
Intrinsic Value
Price

See Also

What is MedCap AB (publ)'s Net Income (Common)?
Net Income (Common)
227.9m SEK

Based on the financial report for Sep 30, 2024, MedCap AB (publ)'s Net Income (Common) amounts to 227.9m SEK.

What is MedCap AB (publ)'s Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
32%

Over the last year, the Net Income (Common) growth was 52%. The average annual Net Income (Common) growth rates for MedCap AB (publ) have been 44% over the past three years , 48% over the past five years , and 32% over the past ten years .

Back to Top